Search academic texts

Information × Registration Number 0303U007691, 0103U008853 , R & D reports Title An open-label, multicenter study to investigate of safety of 2 mg TID of Cilansetron over one year in diarrhoe-predominant irritable bowel syndrome subjects. popup.stage_title Відкрите багатоцентрове дослідження оцінки безпечності застосування 2 мг цилансетрона три рази на день протягом одного року у хворих з синдромом подразненої товстої кишки з переважанням діареї. Head Nykula Taras D., Registration Date 24-11-2003 Organization National Medical University popup.description2 In 17 patients with diarrhorea-predominant irritable bowel syndrome the transplantability and safety of 2 mg cilansetronapplication three times per day during one year was investigated. There was established 100 % efficiency of this preparation (diarrhoea syndrome disappearance in all patients), its good transplantability and safety5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close